 Raymond Estacio
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 19 | 2025 | 2096 | 1.670 |
Why?
| | Community Health Services | 3 | 2017 | 233 | 0.860 |
Why?
| | Albuminuria | 7 | 2023 | 185 | 0.820 |
Why?
| | Diabetes Mellitus, Type 2 | 16 | 2025 | 2537 | 0.820 |
Why?
| | Health Promotion | 4 | 2023 | 759 | 0.680 |
Why?
| | Case Management | 2 | 2012 | 67 | 0.640 |
Why?
| | Hypertension | 9 | 2016 | 1254 | 0.610 |
Why?
| | Community Health Workers | 2 | 2025 | 76 | 0.570 |
Why?
| | Antihypertensive Agents | 7 | 2016 | 508 | 0.530 |
Why?
| | Program Evaluation | 3 | 2017 | 930 | 0.510 |
Why?
| | Renin-Angiotensin System | 2 | 2024 | 77 | 0.500 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2024 | 198 | 0.500 |
Why?
| | Lipoproteins, LDL | 2 | 2017 | 113 | 0.480 |
Why?
| | Primary Health Care | 4 | 2017 | 1809 | 0.470 |
Why?
| | Risk Reduction Behavior | 2 | 2017 | 227 | 0.450 |
Why?
| | Text Messaging | 2 | 2015 | 179 | 0.450 |
Why?
| | Glomerular Filtration Rate | 5 | 2024 | 752 | 0.420 |
Why?
| | Diabetes Mellitus | 3 | 2012 | 1077 | 0.410 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2024 | 623 | 0.400 |
Why?
| | Coronary Disease | 2 | 2012 | 371 | 0.370 |
Why?
| | Nursing Care | 1 | 2012 | 43 | 0.350 |
Why?
| | Colorado | 13 | 2025 | 4629 | 0.330 |
Why?
| | Patient Admission | 1 | 2012 | 203 | 0.320 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 2024 | 101 | 0.310 |
Why?
| | Phosphorus | 1 | 2009 | 98 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 6 | 2024 | 1634 | 0.290 |
Why?
| | Nursing Diagnosis | 1 | 2008 | 18 | 0.280 |
Why?
| | Blood Pressure | 7 | 2016 | 1748 | 0.280 |
Why?
| | Cardiac Output, Low | 1 | 2008 | 46 | 0.270 |
Why?
| | Heart Rate | 2 | 2011 | 821 | 0.270 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 881 | 0.270 |
Why?
| | Community-Institutional Relations | 1 | 2008 | 102 | 0.270 |
Why?
| | Drug Prescriptions | 1 | 2009 | 267 | 0.260 |
Why?
| | Tetrazoles | 1 | 2006 | 45 | 0.250 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 38 | 0.250 |
Why?
| | Valine | 1 | 2006 | 77 | 0.250 |
Why?
| | Middle Aged | 30 | 2025 | 34647 | 0.250 |
Why?
| | Risk Factors | 11 | 2023 | 10482 | 0.240 |
Why?
| | Aged | 21 | 2025 | 24746 | 0.240 |
Why?
| | Blood Pressure Determination | 2 | 2017 | 145 | 0.240 |
Why?
| | Drug Monitoring | 1 | 2009 | 399 | 0.240 |
Why?
| | Diabetic Nephropathies | 3 | 2006 | 299 | 0.220 |
Why?
| | Cohort Studies | 10 | 2012 | 5815 | 0.210 |
Why?
| | Lipids | 1 | 2008 | 690 | 0.200 |
Why?
| | Humans | 43 | 2025 | 141754 | 0.190 |
Why?
| | Telemedicine | 1 | 2012 | 894 | 0.190 |
Why?
| | Nisoldipine | 4 | 2009 | 7 | 0.190 |
Why?
| | Enalapril | 4 | 2009 | 16 | 0.190 |
Why?
| | Diabetic Angiopathies | 5 | 2007 | 251 | 0.180 |
Why?
| | Follow-Up Studies | 9 | 2012 | 5212 | 0.180 |
Why?
| | Medically Underserved Area | 2 | 2015 | 100 | 0.170 |
Why?
| | Adult | 17 | 2022 | 39391 | 0.170 |
Why?
| | Proportional Hazards Models | 5 | 2012 | 1268 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2023 | 169 | 0.170 |
Why?
| | Disease Progression | 3 | 2024 | 2800 | 0.170 |
Why?
| | Life Style | 3 | 2012 | 482 | 0.160 |
Why?
| | Male | 28 | 2025 | 70179 | 0.160 |
Why?
| | Female | 28 | 2025 | 75943 | 0.150 |
Why?
| | Self Care | 2 | 2012 | 395 | 0.150 |
Why?
| | Health Literacy | 1 | 2021 | 176 | 0.140 |
Why?
| | Healthy Lifestyle | 1 | 2017 | 35 | 0.130 |
Why?
| | Poverty | 3 | 2017 | 530 | 0.130 |
Why?
| | Pilot Projects | 3 | 2025 | 1826 | 0.130 |
Why?
| | Prospective Studies | 7 | 2012 | 7777 | 0.130 |
Why?
| | Exercise | 1 | 2008 | 2112 | 0.120 |
Why?
| | Urban Population | 2 | 2017 | 485 | 0.120 |
Why?
| | Diabetic Neuropathies | 3 | 2006 | 95 | 0.120 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 119 | 0.110 |
Why?
| | Educational Status | 1 | 2017 | 464 | 0.110 |
Why?
| | Triglycerides | 1 | 2017 | 514 | 0.110 |
Why?
| | Rural Population | 2 | 2025 | 606 | 0.110 |
Why?
| | Focus Groups | 2 | 2015 | 572 | 0.110 |
Why?
| | Accelerometry | 1 | 2015 | 109 | 0.100 |
Why?
| | Time Factors | 8 | 2024 | 6966 | 0.100 |
Why?
| | Hyperlipidemias | 2 | 2005 | 125 | 0.100 |
Why?
| | Rural Health Services | 1 | 2015 | 141 | 0.100 |
Why?
| | Risk Assessment | 4 | 2011 | 3508 | 0.100 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 454 | 0.100 |
Why?
| | Diabetic Retinopathy | 2 | 2006 | 201 | 0.090 |
Why?
| | Bayes Theorem | 2 | 2024 | 418 | 0.090 |
Why?
| | Geographic Information Systems | 1 | 2011 | 46 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2016 | 7923 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2008 | 3789 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2012 | 136 | 0.090 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 62 | 0.080 |
Why?
| | Guideline Adherence | 2 | 2007 | 566 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 611 | 0.080 |
Why?
| | Algorithms | 2 | 2008 | 1768 | 0.080 |
Why?
| | Registries | 2 | 2009 | 2144 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 720 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2012 | 1570 | 0.080 |
Why?
| | Myocardial Infarction | 3 | 2006 | 1069 | 0.080 |
Why?
| | Fumarates | 1 | 2009 | 10 | 0.080 |
Why?
| | Renin | 1 | 2009 | 34 | 0.080 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2075 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2024 | 11181 | 0.080 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 107 | 0.080 |
Why?
| | Urban Health Services | 1 | 2009 | 69 | 0.080 |
Why?
| | Kidney | 2 | 2024 | 1482 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 619 | 0.070 |
Why?
| | Comorbidity | 3 | 2009 | 1664 | 0.070 |
Why?
| | Risk Management | 1 | 2009 | 93 | 0.070 |
Why?
| | Amides | 1 | 2009 | 100 | 0.070 |
Why?
| | Logistic Models | 3 | 2009 | 2092 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 119 | 0.070 |
Why?
| | Diabetes Complications | 2 | 2009 | 224 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2009 | 1498 | 0.070 |
Why?
| | Minority Groups | 1 | 2010 | 278 | 0.070 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1317 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 96 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 633 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2024 | 16374 | 0.070 |
Why?
| | Electrocardiography | 2 | 2008 | 618 | 0.070 |
Why?
| | Blood Glucose | 1 | 2017 | 2278 | 0.060 |
Why?
| | Motivation | 1 | 2012 | 603 | 0.060 |
Why?
| | Young Adult | 2 | 2015 | 13749 | 0.060 |
Why?
| | Valsartan | 1 | 2006 | 30 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2015 | 1027 | 0.060 |
Why?
| | Kidney Function Tests | 1 | 2006 | 159 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2012 | 2938 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 824 | 0.060 |
Why?
| | Program Development | 1 | 2008 | 368 | 0.060 |
Why?
| | Stroke | 3 | 2003 | 1158 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 409 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 490 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2007 | 333 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1320 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2006 | 280 | 0.050 |
Why?
| | Reagent Strips | 1 | 2004 | 8 | 0.050 |
Why?
| | Mass Screening | 1 | 2012 | 1313 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2012 | 1132 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2024 | 93 | 0.050 |
Why?
| | Calcium | 1 | 2009 | 1192 | 0.050 |
Why?
| | Peripheral Vascular Diseases | 1 | 2003 | 103 | 0.050 |
Why?
| | Incidence | 4 | 2011 | 2806 | 0.050 |
Why?
| | Research Design | 1 | 2008 | 1146 | 0.040 |
Why?
| | Heart Ventricles | 1 | 2006 | 753 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2005 | 779 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2024 | 457 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4080 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1603 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2024 | 678 | 0.030 |
Why?
| | Odds Ratio | 3 | 2005 | 1057 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2010 | 521 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1374 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1656 | 0.030 |
Why?
| | Hospitals | 2 | 2009 | 696 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 22130 | 0.020 |
Why?
| | United States | 3 | 2021 | 15310 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4190 | 0.020 |
Why?
| | Heart Failure | 1 | 2004 | 2093 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 174 | 0.020 |
Why?
| | Information Dissemination | 1 | 2012 | 224 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 114 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5697 | 0.020 |
Why?
| | Medication Errors | 1 | 2009 | 97 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 590 | 0.020 |
Why?
| | Health Surveys | 1 | 2010 | 513 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 697 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 910 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 302 | 0.020 |
Why?
| | Medical Audit | 1 | 2007 | 78 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.020 |
Why?
| | Public Policy | 1 | 2006 | 82 | 0.020 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2012 | 705 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2006 | 184 | 0.010 |
Why?
| | Smoke | 1 | 2006 | 149 | 0.010 |
Why?
| | Hospitalization | 2 | 2006 | 2264 | 0.010 |
Why?
| | Specific Gravity | 1 | 2004 | 11 | 0.010 |
Why?
| | Exercise Test | 1 | 2006 | 624 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 715 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1820 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1972 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 329 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1406 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 750 | 0.010 |
Why?
| | Survivors | 1 | 2006 | 504 | 0.010 |
Why?
| | Hypolipidemic Agents | 1 | 2003 | 92 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2006 | 440 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 3294 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 172 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2003 | 191 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2002 | 289 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 2003 | 361 | 0.010 |
Why?
| | Internet | 1 | 2005 | 690 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 585 | 0.010 |
Why?
| | Patient Discharge | 1 | 2007 | 933 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 1057 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 1130 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 1102 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 1989 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 2385 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2003 | 702 | 0.010 |
Why?
|
|
Estacio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|